Related Experiment Video

Updated: Jun 29, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Rotavirus vaccines: opportunities and challenges

Keith Grimwood1, Stephen B Lambert

  • 1Queensland Paediatric Infectious Diseases Laboratory, Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, University of Queensland, Brisbane, Australia. Keith_Grimwood@health.qld.gov.au

Human Vaccines
|October 8, 2008
PubMed

Insights

Rotavirus vaccines protect young children from severe gastroenteritis, reducing hospitalizations and deaths. Further evaluation is needed in low-income countries to ensure program effectiveness.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Rotavirus gastroenteritis causes over 500,000 deaths and 2.4 million hospitalizations in children annually worldwide.
  • Improved hygiene and living standards have not significantly reduced the rotavirus disease burden, necessitating vaccine development.
  • Rotavirus vaccines aim to mimic natural immunity, protecting children from severe illness.

Purpose of the Study:

  • To review the efficacy and safety of rotavirus vaccines.
  • To assess the performance of rotavirus vaccination programs in various income settings.
  • To identify challenges and potential benefits of rotavirus vaccines in low-income countries.

Main Methods:

  • Review of existing literature on rotavirus vaccine clinical trials and epidemiological data.
  • Analysis of vaccine effectiveness in high, middle, and low-income countries.
  • Evaluation of factors influencing vaccine immunogenicity and program delivery.

Main Results:

  • Licensed rotavirus vaccines are safe and well-tolerated.
  • Vaccines demonstrate 80-100% protection against severe rotavirus gastroenteritis in high and middle-income countries.
  • Effectiveness in low-income countries requires further evaluation due to potential challenges like reduced immunogenicity and logistical issues.

Conclusions:

  • Rotavirus vaccines are a crucial tool for reducing childhood mortality and morbidity globally.
  • Addressing challenges in low-income settings is essential for maximizing the impact of rotavirus immunization programs.
  • Successful implementation can significantly decrease the 5% of childhood deaths attributed to rotavirus gastroenteritis.

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations01:51

Vaccinations

Overview